The Hyperliquid Policy Center has accused CME Group of holding back innovation as it calls on a court to dismiss the exchange’s lawsuit against the US Commodity Futures Trading Commission (CFTC).
The policy centre has backed the CFTC in the legal dispute, arguing that CME Group’s case should not proceed. Its intervention places the debate over perpetual futures at the centre of the disagreement between the exchange and the regulator.
Perpetual futures are at the heart of the issue identified in the original title, while the Hyperliquid Policy Center’s submission focuses on what it describes as the wider consequences of CME Group’s legal action.
The centre said CME Group was “stifling innovation” and urged the court to reject the exchange’s challenge to the CFTC. It has therefore taken a position in support of the regulator rather than the claimant in the case.
No further details about the court, the legal grounds of CME Group’s complaint or the CFTC’s response were provided in the source material. The central development is the Hyperliquid Policy Center’s request for dismissal and its criticism of CME Group’s approach.
The case places two competing arguments before the court. CME Group has brought a lawsuit against the CFTC, while the Hyperliquid Policy Center says the exchange’s action risks restricting innovation. The policy centre’s argument is that the legal challenge should be dismissed.
Its intervention also highlights the importance of perpetual futures in the dispute. The original title identifies the products as the subject of the wider fight, although the available information does not set out the specific legal questions surrounding them.
The Hyperliquid Policy Center’s position is consequently clear: it supports the CFTC and wants the court to end CME Group’s lawsuit. Its criticism of CME Group centres on the claim that the exchange is seeking to stifle innovation.
The source does not state whether the court has ruled on the request, nor does it provide a timetable for any decision. It also does not give details of any immediate response from CME Group or the CFTC.
For now, the reported action consists of the policy centre’s backing for the regulator and its appeal to the court. The dispute remains framed around CME Group’s lawsuit against the CFTC, the future of perpetual futures and the competing claims over innovation in the market.
